Researchers generated mouse models carrying single-copy mutant human SOD1 genes
Original source
Generation of mutant human SOD1 knock-in mouse lines at the Rosa26 locus as a platform for developing genome-editing therapies for amyotrophic lateral sclerosis. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Mouse
Population inferred from the title and abstract by Compass.
Related topics
Researchers used CRISPR/Cas9 gene editing to create mice carrying single-copy human SOD1 genes with the L126S or G93S mutation. The models were designed to support preclinical testing of genome-editing treatments for SOD1-related amyotrophic lateral sclerosis (ALS).
Why this matters
These mice could help researchers assess whether genome-editing approaches can target disease-causing SOD1 mutations in living animals. The work does not show that any treatment works and does not change treatment for people with ALS.
Limitations and context
This was a mouse-model study, not a treatment study in people. During the limited observation period, the L126S mice did not develop ALS-like features, so the model’s ability to reproduce disease remains limited. The study established a research platform, but its usefulness for predicting treatment effects still needs to be demonstrated.